SCHEMBL21099698

SCHEMBL21099698

C[C@H](O)[C@@H](CO)OC(C)(C)n1ccc(N)nc1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.38
SLC22A6 Q4U2R8 1/20 0.37
LMNA P02545 3/20 0.35
THRB P10828 1/20 0.35
MTOR P42345 1/20 0.35
MDM2 Q00987 1/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
PDE3A Q14432 3/20 0.33
PDE4D Q08499 1/20 0.33
SLC29A1 Q99808 1/20 0.33
NT5E P21589 1/20 0.32
CACNA1F O60840 2/20 0.32
ALB P02768 2/20 0.32
MAPT P10636 2/20 0.32
CACNA1D Q01668 2/20 0.32
CACNA1S Q13698 2/20 0.32
CACNA1C Q13936 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16330681 0.77 FGFR1 (0.37) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL18482197 0.75 FGFR1 (0.36) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL19594014 0.74 FGFR1 (0.39) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL20058767 0.74 FGFR1 (0.39) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL13254100 0.74 FGFR1 (0.50) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL14392683 0.74 FGFR1 (0.50) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL13897580 0.74 FGFR1 (0.50) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL13769510 0.74 FGFR1 (0.39) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL23950133 0.74 FGFR1 (0.37) FGFR1SLC22A6LMNATHRBMTOR
SCHEMBL22847460 0.74 FGFR1 (0.37) FGFR1SLC22A6LMNATHRBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697241-B1 1'-SUBSTITUTED PYRIMIDINE N-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES INC (US) 2019-06-12 EP disclosed